On the HCPLive Major Depressive Disorder condition center page, resources on the topics of medical news and expert insight into depression can be found. Content includes articles, interviews, videos, podcasts, and breaking news on MDD research, treatment, and drug development.
November 1st 2024
In a recent phase 2a trial, SPN-820, a novel intracellular moderator of mTORC1, decreased suicidal ideation by 80%.
October 23rd 2024
Home Exercise Reduces Hopelessness in Patients with Coronary Heart Disease
A study presented at the American Heart Association (AHA) Scientific Sessions 2014 reported home exercise could potentially alleviate feelings of hopelessness in people afflicted with coronary heart disease.
Hypothyroidism and the Brain: Attributing Nuisance Symptoms to a Faulty Thyroid
November 15th 2014Thyroid dysfunction causes many well-recognized changes at the level of the brain, and most are reversible with treatment. Patients who have hypothyroidism often have other neuropsychiatric comorbidities, including affective disorders, depression, cognitive function loss, anxiety, or irritability.
Using Prolonged Exposure Therapy to Help Veterans Work through PTSD Symptoms
October 25th 2014Prolonged exposure therapy can help veterans with post-traumatic stress disorder overcome the fear, anxiety, and depression that can lead to avoidance behaviors and other responses that negatively impact quality of life.
Adolescent Depression: Do Your Patients Have a Trusted Adult to Talk With?
October 24th 2014Adolescent depression is a serious mental illness that results in negative health consequences and frequently recurs later in life. Although the prevalence rate of depression is around 20 percent among African American and European-American adolescents, the associated risks and utilization rates vary greatly.
Delving Into Adherence With Multiple Sclerosis Therapies
September 16th 2014Adherence is defined as conforming to the recommendations made by the provider with respect to timing, dosage, and frequency of medication taking, and following these recommendations is important for patients with multiple sclerosis (MS) to fully benefit from disease-modifying therapies (DMTs).